These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Visual issues in multiple sclerosis. Francis CE Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):687-702. PubMed ID: 24314686 [TBL] [Abstract][Full Text] [Related]
11. [Infections and fingolimod]. Cervera C Rev Neurol; 2012 Aug; 55(4):227-37. PubMed ID: 22829086 [TBL] [Abstract][Full Text] [Related]
12. Famous. Kim MJ; Bhatti MT; Costello F Surv Ophthalmol; 2016; 61(4):512-9. PubMed ID: 26742785 [TBL] [Abstract][Full Text] [Related]
14. FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model. Zhang J; Song Z; Wijkström M; Bari S; Sundberg B; Nava S; Groth CG; Korsgren O; Wennberg L Transplant Proc; 2000 Aug; 32(5):1017. PubMed ID: 10936327 [No Abstract] [Full Text] [Related]
15. [Molecular action mechanisms of the therapeutic agents for kidney diseases: Immunosuppressants]. Nishikido M; Kanekake H; Harada T Nihon Rinsho; 2006 Feb; 64 Suppl 2():634-8. PubMed ID: 16523968 [No Abstract] [Full Text] [Related]
16. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)]. Popova NF Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):110-3. PubMed ID: 21916166 [No Abstract] [Full Text] [Related]